Hiroaki Ohata
Designation: Director / Medical Affairs Lead Autoimmune Diseases Products, Bio-Medicines Japan Drug Development and Medical Affairs & Medical Affairs Committee Working Group 3
Department: Eli Lilly Japan K.K. / PhRMA
Designation: Director / Medical Affairs Lead Autoimmune Diseases Products, Bio-Medicines Japan Drug Development and Medical Affairs & Medical Affairs Committee Working Group 3
Department: Eli Lilly Japan K.K. / PhRMA